Rare diseases
Investigational molecules
Locations
706 conditions with trials, the busiest first
3 924 trials across Europe, recruiting first
Study on Melphalan and Drug Combination for Low and Intermediate Risk Neuroblastoma Patients
GermanyStudy on the Effectiveness of Valganciclovir for Patients with Glioblastoma
NorwayTesting Drug Combinations with GSK4381562A, GSK6097608, GSK4428859 and Dostarlimab in Patients with PD-L1 Positive Head and Neck Cancer That Has Spread or Returned
DenmarkStudy on Long-Term Safety and Efficacy of Lunsekimig for Adults with Chronic Rhinosinusitis with Nasal Polyps
BelgiumStudy on Itepekimab for Adults with Chronic Rhinosinusitis and Nasal Polyps
AustriaStudy of AMG 193 tablets for patients with advanced non-small cell lung cancer (NSCLC) who have previously received treatment and have MTAP gene deletion
BelgiumStudy on the Effectiveness and Safety of AZD0901 Compared to Standard Treatments for Adults with Advanced Gastric or Gastroesophageal Junction Cancer Expressing Claudin 18.2
FranceStudy of Durvalumab and Chemotherapy for Patients with Resectable Non-Small Cell Lung Cancer
AustriaStudy Comparing Ivonescimab with Chemotherapy to Pembrolizumab with Chemotherapy for Patients with Metastatic Squamous Non-Small Cell Lung Cancer
BelgiumStudy on the Effects of SAR443765 and Mometasone Furoate in Adults with Chronic Rhinosinusitis with Nasal Polyps
BelgiumStudy of RVU120 and Ruxolitinib for Patients with Intermediate or High-Risk Myelofibrosis
ItalyStudy on Basimglurant for Children, Adolescents, and Young Adults with Tuberous Sclerosis Complex-Related Seizures
ItalyThe therapies tested most often in Neoplasms benign, malignant and unspecified (incl cysts and polyps) trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
